ATE374203T1 - Therapeutische verbindungen und verfahren - Google Patents

Therapeutische verbindungen und verfahren

Info

Publication number
ATE374203T1
ATE374203T1 AT01947052T AT01947052T ATE374203T1 AT E374203 T1 ATE374203 T1 AT E374203T1 AT 01947052 T AT01947052 T AT 01947052T AT 01947052 T AT01947052 T AT 01947052T AT E374203 T1 ATE374203 T1 AT E374203T1
Authority
AT
Austria
Prior art keywords
procedures
therapeutic compounds
compounds
therapy
compositions
Prior art date
Application number
AT01947052T
Other languages
German (de)
English (en)
Inventor
Barbara Meurer-Grimes
Jin Yu
Gino Vairo
Original Assignee
Government Of The State Of Sar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Government Of The State Of Sar filed Critical Government Of The State Of Sar
Application granted granted Critical
Publication of ATE374203T1 publication Critical patent/ATE374203T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01947052T 2000-07-05 2001-07-05 Therapeutische verbindungen und verfahren ATE374203T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ8665A AUPQ866500A0 (en) 2000-07-05 2000-07-05 Therapeutic compounds and methods

Publications (1)

Publication Number Publication Date
ATE374203T1 true ATE374203T1 (de) 2007-10-15

Family

ID=3822729

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01947052T ATE374203T1 (de) 2000-07-05 2001-07-05 Therapeutische verbindungen und verfahren

Country Status (10)

Country Link
US (1) US6710075B2 (OSRAM)
EP (1) EP1303520B1 (OSRAM)
JP (1) JP2004501983A (OSRAM)
AT (1) ATE374203T1 (OSRAM)
AU (1) AUPQ866500A0 (OSRAM)
CA (1) CA2411818C (OSRAM)
DE (1) DE60130659T2 (OSRAM)
ES (1) ES2295176T3 (OSRAM)
PT (1) PT1303520E (OSRAM)
WO (1) WO2002002566A1 (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1569928A4 (en) * 2002-11-08 2008-12-10 Government Of The State Of Sar THERAPEUTIC COMPOUNDS AND METHOD
WO2006007634A1 (en) * 2004-07-16 2006-01-26 Cerylid Biosciences Ltd Processes and intermediates
EP2189158A1 (en) * 2008-11-20 2010-05-26 DKFZ Deutsches Krebsforschungszentrum, Stiftung des Öffentlichen Rechts Combination of rocaglamide and apoptosis inducing substances for the treatment of cancer
WO2011140334A2 (en) * 2010-05-06 2011-11-10 Trustees Of Boston University Compounds, methods of making or identifying compounds, and uses thereof
FR3023290B1 (fr) * 2014-07-04 2016-08-19 Pf Medicament Derives de flavaglines
US10639378B2 (en) 2016-06-06 2020-05-05 Genentech, Inc. Silvestrol antibody-drug conjugates and methods of use
AU2019221837B2 (en) 2018-02-19 2024-08-01 Memorial Sloan-Kettering Cancer Center Agents and methods for treating dysproliferative diseases
CN110279687A (zh) * 2019-07-15 2019-09-27 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 一种抗肿瘤药物
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
MY194199A (en) * 2020-08-11 2022-11-21 The Government Of The State Of Sarawak Malaysia A composition for the treatment of autoimmune diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656296A (en) 1983-06-01 1987-04-07 Sun Chemical Corporation Novel compounds and their use as insolubilizers for binders for paper coating compositions
WO1996004284A1 (en) 1994-08-04 1996-02-15 Novartis Ag Insecticidal polycyclic compounds
JPH0967360A (ja) 1995-08-28 1997-03-11 Terumo Corp 癌遺伝子機能抑制剤
WO1997008161A1 (en) 1995-08-28 1997-03-06 Terumo Kabushiki Kaisha Oncogene function depressant
JPH1112279A (ja) 1997-06-27 1999-01-19 Microbial Chem Res Found Ｒａｓ蛋白の阻害活性を有する新規なアグライアスタチン立体異性体とそれらの製造法
DE19934952A1 (de) * 1998-07-30 2000-02-03 Novartis Ag Cyclopentabenzofuran-Derivate
DE19835324A1 (de) 1998-08-05 2000-02-10 Bayer Ag Cyclopentabenzofuran-Derivate und ihre Verwendung
DE19835325A1 (de) * 1998-08-05 2000-02-10 Bayer Ag Verwendung von Cyclopentabenzofuran-Derivaten zur Bekämpfung von NF-kB abhängigen Krankheiten

Also Published As

Publication number Publication date
EP1303520A4 (en) 2005-03-30
US6710075B2 (en) 2004-03-23
CA2411818A1 (en) 2002-01-10
WO2002002566A1 (en) 2002-01-10
DE60130659D1 (de) 2007-11-08
EP1303520B1 (en) 2007-09-26
DE60130659T2 (de) 2008-07-17
ES2295176T3 (es) 2008-04-16
CA2411818C (en) 2011-02-22
EP1303520A1 (en) 2003-04-23
JP2004501983A (ja) 2004-01-22
US20030181514A1 (en) 2003-09-25
PT1303520E (pt) 2008-01-07
AUPQ866500A0 (en) 2000-08-03

Similar Documents

Publication Publication Date Title
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
DE60112974D1 (en) Carbolinderivate
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
GEP20084488B (en) Use of therapeutic agents for treating pain
TW200626526A (en) Pharmaceutical compositions for the treatment of neoplasms
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
PT1263725E (pt) Novos compostos
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
NO20024610D0 (no) Synergistiske metoder og blandinger for behandling av kreft
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
HUP0401190A3 (en) Treatment of nail infections using no generating compositions
IL161744A (en) Use of zd6474 and taxane in the manufacture of a medicament for the treatment of cancer and pharmaceutical compositions and kits comprising such compounds
AU1328502A (en) Novel targeted compositions for diagnostic and therapeutic use
DE60216233D1 (en) Carbolinderivate
NO20042208L (no) Vaginalt administrerte anti-dysrytmiske midler for behandling av bekkensmerter
AU5160201A (en) Compositions comprising natural agents for treatment of cancer
CR7193A (es) Pirrolopirimidinas como inhibidores de la protenina kinasa
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
SE0101932D0 (sv) Pharmaceutical combinations
ATE374203T1 (de) Therapeutische verbindungen und verfahren
DE60129829D1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
EE200300201A (et) Püranoonsete proteaasi inhibiitorite iseemulgeeruva kompositsiooni oraalne doos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1303520

Country of ref document: EP